Programmed death-ligand 1 (PD-L1) is an important biomarker that facilitates tumor immune evasion by binding to the PD-1 receptor on T cells and suppressing their activation through its overexpression on tumor cells [32]. This evidence concerns the gene CD274 and neoplasm.